- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00463229
Interdisciplinary Team Approach to Stroke Rehabilitation in Home Care
The Comparative Acceptability, Safety, Effects and Expense of Specialized, Integrated, and Interdisciplinary Community Rehabilitation for Stroke Survivors and Their Caregivers
Study Overview
Detailed Description
Stroke is the third leading cause of death in Canada, and is considered to be the most common disabling chronic condition. Approximately 40,000 to 50,000 people in Canada experience a stroke each year and about 80% of these people survive. Many of these people who survive a stroke never fully recover and are left with significant impairments and disabilities, and 12% to 25% will have another stroke within the first year. This results in a significant burden to individuals, families, and society as a whole. Of every 100 people who are hospitalized for a stroke, 15-40 return home and require home care services for rehabilitation. Stroke rehabilitation is one of the key components of stroke care. The goal of rehabilitation is to assist stroke survivors to reach his or her optimal level of physical, social, and emotional function.
Information gained from this study will be used to inform home care practice, policy decisions and the allocation of home care resources and make a national contribution to health care delivery reform.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 3Z5
- School of Nursing, McMaster University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosis of stroke or TIA has been confirmed.
- newly referred to and eligible for home care services (physiotherapy, speech language therapy, occupational therapy, nursing) through the Toronto Central CCAC.
- living at home in the community (outside of an institutional setting) up to 18-months post-stroke.
- English speaking
Exclusion Criteria:
- refuse to give informed consent.
- more than 18 months post-stroke at time of recruitment.
- unable to read/write English and an appropriate translator is not available.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interprofessional Team Approach
Participants in the experimental group will receive home care services from a team of professional service providers [Community Care Access Centre (CCAC) Care Coordinator, Registered Nurse, Occupational therapist, Physiotherapist, Speech language pathologist, Nutritionist] and non-professional service providers (personal support workers) with experience and training in stroke care.
The team will provide a comprehensive, coordinated and evidence-based approach to stroke rehabilitation through weekly case conferencing, a written interdisciplinary care plan, and joint visits.
|
Subject in the second group will receive home care services from a team of professional service providers (CCAC Care Coordinator, Registered Nurse, Occupational therapist, Physiotherapist, Speech language pathologist, Nutritionist) and non-professional service providers (personal support workers) with experience and training in stroke care.
The team will provide a comprehensive, coordinated and evidence-based approach to stroke rehabilitation through weekly case conferencing, a written interdisciplinary care plan, and joint visits.
Other Names:
|
|
No Intervention: Usual Home Care Services
Participants allocated to the control group received standard home care services arranged by the CCAC.
These include routine follow-up by the CCAC case manager whose focus is on assessment and referral to community agencies, and ongoing monitoring and evaluating the plan of care through in-home assessment with clients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change Between the Value of the SF-36 Physical Function Score at 12 Months Minus Value at Baseline to Measure the Change in Health-related Quality of Life and Function
Time Frame: Baseline (pre-randomization) and 12 months
|
The primary measure of effect was the change in health-related quality of life and functioning from baseline to 12-months as measured by the SF-36 physical functioning score.
The range of possible scores for this subscale is 0-100, with a higher score indicating a more favourable health status.
|
Baseline (pre-randomization) and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stroke Impact Scale - 16
Time Frame: Baseline (pre-randomization) and 12 months
|
The SIS-16 assesses several aspects of health-related quality of life that are important to stroke survivors, caregivers, and healthcare professionals.
The SIS-16 consists of 16 items which cover the physical aspects of stroke including: strength, hand function, mobility, and activities of daily living/instrumental activities of daily living.
Each item is assigned a score ranging from 1 (could not do at all) to 5 (not difficult at all).
The individual items sum to provide a total score (range from 16 to 80), with higher scores indicating higher levels of health-related quality of life and function.
|
Baseline (pre-randomization) and 12 months
|
|
Reintegration to Normal Living Index
Time Frame: Baseline (pre-randomization) and 12 months
|
The RNLI assesses global functional status and measures both the stroke survivors' perceptions of their own capabilities and objective indicators of physical, social, and psychological performance.
The RNLI consists of 11 items which cover the domains of mobility, self-care abilities, daily activities, recreational and social activities, family roles, and personal relationships, presentation of self and general coping skills.
Each item is scored as 0 to 2. Minimum score is "0" and maximum score is "22".
The individual items sum to provide a total score, with 22 indicating the highest degree of reintegration.
|
Baseline (pre-randomization) and 12 months
|
|
Short Portable Mental Status Questionnaire.
Time Frame: Baseline (pre-randomization) and 12 months
|
The 10-item Short Portable Mental Status Questionnaire (SPMSQ) is used for the screening, diagnosis and assessment of cognition.
The SPMSQ is short, easily administered and has been designed, tested, standardized and validated in a variety of populations, including stroke.
The SPMSQ consists of 10 items.
The individual items sum to provide a total score, ranging from 0-10; with greater than 4 errors indicating some degree of intellectual impairment.
The higher the score, the less impairment.
|
Baseline (pre-randomization) and 12 months
|
|
Centre for Epidemiological Studies in Depression Scale (CES-D)
Time Frame: Baseline and 12 months
|
The CES-D scale is a 20-item, self-reported questionnaire that assesses the current frequency of depressive symptoms.
Total scores can range from 0 to 60; the higher the score, the more depressed.
Values were determined by taking the value of the 12-month data (Timepoint 2) and subtracting them from the baseline data (Timepoint 1).
|
Baseline and 12 months
|
|
Personal Resource Questionnaire (PRQ85-Part Two)
Time Frame: Baseline (pre-randomization) and 12 months
|
The PRQ85-Part Two is a 25-item scale that measures perceived social support along five dimensions: provision for attachment/intimacy; social integration; opportunity for nurturing behaviour; reassurance of worth as an individual and in role accomplishments; and the availability of informational, emotional, and material help.
Scores range from a minimum of 25 to maximum score of 175; a higher score indicates a greater perception of social support.
|
Baseline (pre-randomization) and 12 months
|
|
Kessler - 10
Time Frame: Baseline (pre-randomization) and 12 months
|
The Kessler-10 assesses level of anxiety and depressive symptoms a person may have experienced in the most recent four-week period.
Its main strength is a superior ability to screen for anxiety and affective disorders.
Each item is assigned a score ranging from 5 (all of the time) to 1 (none of the time).
These 10 items are summed to give scores ranging from 10-50, where 50 indicates high risk of anxiety or depressive disorder.
Previous studies have established a cut-off score of 16-29/50 for medium risk, and 30-50/50 as high risk for anxiety and depressive disorders.
|
Baseline (pre-randomization) and 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Maureen Markle-Reid, RN MScN PhD, McMaster University, School of Nursing
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHE-78692
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Interprofessional Team Approach
-
Yale UniversityCompletedElectronic Fetal MonitoringUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
University of ArizonaUniversity of Massachusetts, AmherstRecruitingHypertension | Medication AdherenceUnited States
-
University of AdelaideCentral Adelaide Local Health Network IncorporatedCompletedObesity | Bariatric Surgery Candidate
-
Jewish General HospitalGenzyme, a Sanofi CompanyWithdrawn
-
University of OuluUnknown
-
The University of Texas Health Science Center,...DHR Health Institute for Research and DevelopmentCompletedType 2 DiabetesUnited States
-
University of Turin, ItalyFondazione CRT, TorinoNot yet recruitingKnowledge, Attitudes, Practice | Self Efficacy | Interprofessional RelationsItaly
-
Yousaf JanCompletedBreast Cancer Stage I | Breast Cancer Female | Breast CancersPakistan
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Respiratory Insufficiency | Respiratory Distress Syndrome, NewbornUnited States